Arcus Biosciences Inc (RCUS)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	117,000	119,355	121,236	118,995	112,000	433,144	408,724	399,137	398,304	53,292	108,361	92,939	77,517	77,780	15,000	15,000	15,000	6,812	9,353	8,853
Receivables	US$ in thousands	4,000	4,000	35,000	36,000	43,000	29,944	38,916	32,008	746,762	2,818	2,724	5,953	1,592	372	239	—	251	0	62	0
Receivables turnover		29.25	29.84	3.46	3.31	2.60	14.47	10.50	12.47	0.53	18.91	39.78	15.61	48.69	209.09	62.76	—	59.76	—	150.85	—

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $117,000K ÷ $4,000K
= 29.25

The receivables turnover of Arcus Biosciences Inc has fluctuated over the past eight quarters, ranging from a low of 2.14 in Q3 2023 to a high of 14.10 in Q3 2022. Generally, a higher receivables turnover ratio indicates that the company is collecting its accounts receivable more efficiently.

In Q3 2022, the receivables turnover ratio spiked to 14.10, which suggests that the company was very efficient in collecting its accounts receivable during that period. However, this ratio dropped significantly in subsequent quarters but remained above 3, indicating a relatively efficient collection process overall.

It is important to note that a very high or very low receivables turnover ratio may warrant further investigation into the company's credit policies, customer payment behavior, or changes in industry dynamics that could be influencing these fluctuations. Overall, the receivables turnover ratio provides valuable insight into how efficiently Arcus Biosciences Inc is managing its accounts receivable and collecting payments from customers.